| Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis (NCT05267262) | River 3 Renal Corp. | 2022-06-15 |
| NEPTUNE Match Study (NCT04571658) | University of Michigan | 2022-05-02 |
| Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants (NCT05133050) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2022-01-01 |
| Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases (NCT05003986) | Travere Therapeutics, Inc. | 2021-08-12 |
| Atrasentan in Patients With Proteinuric Glomerular Diseases (NCT04573920) | Novartis Pharmaceuticals | 2021-03-15 |
| Genotype-Phenotype Correlations in Patients With Alport Syndrome (NCT04947813) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2021-01-01 |
| Study of Lademirsen (SAR339375) in Patients With Alport Syndrome (NCT02855268) | Genzyme, a Sanofi Company | 2019-11-02 |
| An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (NCT03749447) | Biogen | 2019-03-08 |
| A Study of RG-012 in Subjects With Alport Syndrome (NCT03373786) | Genzyme, a Sanofi Company | 2017-12-22 |
| Eurbio-Alport (RaDiCo Cohort) (RaDiCo Eurbio-Alport) (NCT05927467) | Institut National de la Santé Et de la Recherche Médicale, France | 2017-05-09 |
| A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL (NCT03019185) | Biogen | 2017-03-02 |
| Human Urine Sample Collection for Alport Nephropathy Biomarker Studies (NCT01602835) | Novartis Pharmaceuticals | 2012-09-01 |
| Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study (NCT01696253) | University of Minnesota | 2012-09-01 |
| Urinary Biomarkers of the Progression of Alport Kidney Disease (NCT01705132) | University of Minnesota | 2012-06-01 |
| National Registry of Rare Kidney Diseases (NCT06065852) | UK Kidney Association | 2009-11-06 |
| Alport Syndrome Treatments and Outcomes Registry (NCT00481130) | University of Minnesota | 2007-09-01 |
| A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome (NCT00622544) | University of Minnesota | 2007-07-01 |
| Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome (NCT00309257) | Mario Negri Institute for Pharmacological Research | 2004-01-01 |
| Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome (NCT02378805) | University Hospital Goettingen | 1995-07-01 |